| May 11 2021 |
Brexit and novel food procedures |
Keller and Heckman LLP |
| May 10 2021 |
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term |
Sheppard, Mullin, Richter & Hampton LLP |
| May 10 2021 |
The American Families Plan & A Call for Drug Pricing Legislation |
Mintz |
| May 10 2021 |
FDA Notice Concerning “Healthy” Symbol |
Keller and Heckman LLP |
| May 10 2021 |
CNIL Issues Provisional Recommendations for Remote Quality Control of Clinical Trials During the Health Crisis |
McDermott Will & Schulte LLP |
| May 10 2021 |
Alabama Legislature Approves Medical Marijuana: Roll Tide! (and a Joint?) |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| May 8 2021 |
FDA Proposes Risk-Based and Remote Inspection Strategies in New Report |
Sheppard, Mullin, Richter & Hampton LLP |
| May 7 2021 |
FDA Releases Forward-Looking Report on Inspections |
Keller and Heckman LLP |
| May 7 2021 |
Court Issues a Rare, Severe Discovery Sanction: The Path that Led to Default Judgment |
Nelson Mullins |
| May 7 2021 |
EC Review of Its Recommendation on the Definition of Nanomaterial Includes Targeted Stakeholder Consultation |
Bergeson & Campbell, P.C. |
| May 7 2021 |
Clinical Trials: Does FDA’s Notice to Acceleron Signal a New Era of Enforcement for Results Reporting? |
Foley & Lardner LLP |
| May 7 2021 |
HHS Exemptions for Buprenorphine (But not Methadone) Prescribers |
K&L Gates LLP |
| May 7 2021 |
Brexit and food additive authorisation procedures |
Keller and Heckman LLP |
| May 6 2021 |
In Historic Vote, Alabama House of Representatives Passes Medical Cannabis Bill |
Bradley Arant Boult Cummings LLP |
| May 6 2021 |
Girl Scout Troop Teams Up with Wing for Drone Cookie Deliveries |
Robinson & Cole LLP |
| May 6 2021 |
EFSA Finds Titanium Dioxide is Not Safe for Food |
Keller and Heckman LLP |
| May 6 2021 |
FDA Ups the Ante and Sends First Notice of Noncompliance for Failure to Submit Clinical Trial Results |
Mintz |
| May 6 2021 |
Philadelphia Will Ban Pre-Employment Marijuana Testing in 2022 |
Jackson Lewis P.C. |
| May 6 2021 |
EC To Hold Webinar On Biotechnology IP |
Bergeson & Campbell, P.C. |
| May 5 2021 |
California Court Upholds Employer’s Refusal To Hire Applicant Who Failed Pre-Employment Drug Test Due To Medical Marijuana Use |
Jackson Lewis P.C. |
| May 5 2021 |
FDA Issues Two Warning Letters for Undeclared Allergens |
Keller and Heckman LLP |
| May 4 2021 |
EFSA’s Updated Administrative Guidance on Food-Contact Materials Subject to Authorizations Now in Effect |
Keller and Heckman LLP |
| May 3 2021 |
FDA Adds Eight New Substances to its Inventory of Effective FCS Notifications - May 2021 |
Keller and Heckman LLP |
| May 3 2021 |
NY Attorney General Probes Arsenic in Baby Cereal |
Keller and Heckman LLP |
| May 3 2021 |
New York Amends its Off-Duty Conduct Law to Account for Marijuana Use |
Mintz |
| May 1 2021 |
Marijuana Laws Affecting the Workplace: Tools Employers Can Use to Stay Ahead During High Times |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 30 2021 |
New York State Legalizes Recreational Marijuana: What Employers Need to Know |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 30 2021 |
EU Considers Benefits of New Genomic Techniques |
Keller and Heckman LLP |
| Apr 30 2021 |
EPA Announces Updates to Confidential Status of Chemicals on the TSCA Inventory |
Bergeson & Campbell, P.C. |
| Apr 30 2021 |
Whole Grain Claims to Include Whole Grain Content |
Keller and Heckman LLP |
| Apr 30 2021 |
Important European Court of Justice decision on adding non-organic ingredients to organic drinks |
Keller and Heckman LLP |
| Apr 29 2021 |
FDA Signals Reporting Requirements for Clinical Trials Enforcement with First-ever Notice of Noncompliance to Drug Maker |
Womble Bond Dickinson (US) LLP |
| Apr 29 2021 |
“Buy American” Update: Essential Medicines May Continue to Come From Abroad (For Now) |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 28 2021 |
DC Attorney General Sues Baby Food Company Over Heavy Metals |
Keller and Heckman LLP |
| Apr 28 2021 |
FDA Releases Ambitious Action Plan for Further Reducing Children’s Exposure to Toxic Elements from Foods |
Mintz |
